2014AAGPAnnualMeeting

March14–17,2014TheRenaissanceOrlandoat

SeaWorldOrlando,Florida

InformationonContinuingMedicalEducationandContinuingEducationforthe2014AAGPAnnualMeeting

 

This activity is sponsored by AAGP. 

 

 

   

2  

Thispacketdescribesthepoliciesgoverningthecontinuingeducationandcontinuingmedicaleducationpoliciesofthe2014AAGPAnnualMeeting.Creditfortheseeducationalprogramsmaybeclaimedbyphysicians,nurses,psychologistsandsocialworkers.Toclaimcredit,completetheonlineevaluationsandattendancerecordfoundatwww.AAGPonline.orgoremailedtoyou.PHYSICIANS–CMEACCREDITATIONSTATEMENTTheAmericanAssociationforGeriatricPsychiatryisaccreditedbytheAccreditationCouncilforContinuingMedicalEducation(ACCME)toprovidecontinuingmedicaleducationforphysicians.CREDITDESIGNATIONSTATEMENTTheAmericanAssociationforGeriatricPsychiatrydesignatesthisliveactivityforamaximumof29.5AMAPRACategory1Credit(s)™.Physiciansshouldclaimonlythecreditcommensuratewiththeextentoftheirparticipationintheactivity.Thisformservesasyourcertificateofattendance.NURSINGCONTINUINGEDUCATIONUponcompletionofthiscourse,nursesareeligiblefor29.5contacthours.ProviderapprovedbytheCaliforniaBoardofRegisteredNursing,provider#14251.Thiscertificatemustberetainedforaperiodof4years.SOCIALWORKCONTINUINGEDUCATIONContinuingEducationcreditisco‐sponsoredandprovidedbyCommonwealthEducationalSeminars(CES).SocialWorkers:CES,#1117,isapprovedasaProviderforSocialWorkContinuingEducationbytheAssociationofSocialWorkBoards(ASWB,400SouthRidgeParkway,SteB,Culpepper,VA22701)www.aswb.org.ASWBApprovalPeriod:10/6/12‐12/31/15.Socialworkersshouldcontacttheirregulatoryboardtodeterminecourseapproval.SocialWorkersreceive29.5continuingeducationclockhoursinparticipatinginthiscourse.PSYCHOLOGYEDUCATIONPsychologists:CESisapprovedbytheAmericanPsychologicalAssociationtosponsorContinuingEducationforPsychologists.Psychologistscompletingthisprogramreceive29.5ContinuingEducationHourscredit.CESmaintainsresponsibilityforthisprogram.TARGETAUDIENCE:Theeducationaldesignofthisactivityaddressestheneedsofphysicians,nurses,psychologists,socialworkers,andotherhealthcareprovidersinvolvedinthetreatmentofpatientswithlate‐lifementalillness.PROGRAMOVERVIEW–StatementofNeed:TheAAGPprovidesleadershipinthedevelopmentandimplementationofeducationalactivitiestoenhancetheabilityofpsychiatrists,geriatricians,physicians,nurses,psychologists,socialworkers,andotherhealthcareprofessionalstorecognizeandaddressthespecialmentalhealthneedsofthegeriatricpopulation.TheeducationalactivitiesoftheAnnualMeetingaredeterminedbyaprocessthatbeginswiththeAAGPAnnualMeetingProgramCommitteedeterminingtheeducationalneedusingaseriesofassessments,includingconsultationwiththeBoardofDirectorsandnationallyrecognizedexpertsingeriatricpsychiatry,topicsurveysofAAGPmembers,evaluationsfrompreviousmeetings,andinputfromtheAAGPResearch,ClinicalPractice,andTeachingandTrainingCommittees.TheAAGPAnnualMeetingProgramCommitteedevelopsaseriesofLearningObjectivesforeachAnnualMeeting.EverysessionproposalisreviewedbytheAnnualMeetingProgramCommitteeandselectedbasedoncontentconsistentwithprogram’svisionandlearningobjectives.Gapsineducationalcontentareidentifiedandadditionalsessionsaresolicitedtoensureawell‐balancedcomprehensiveeducationalprogram.Acomprehensivereviewandevaluationprocessbeginsandendswithassessingtheneedsofthe

3  

participants.Theself‐reviewprocesscoupledwithparticipantfeedbackallowsAAGPtoenhanceitseducationalactivitieseachyear.

PROGRAMOBJECTIVESIn2014,theAnnualMeetingprogramobjectivesfocusonevidence‐basedtreatmentsoflate‐lifementalillness,specificallywithafocusonempoweringhealthcareproviders,patients,andfamilieswiththeinformationandtoolstheyneedforqualitymentalhealthcare.In2014,theAnnualMeetingprogramobjectivesfocusonevidence‐basedtreatmentsoflate‐lifementalillness,specificallywithafocusonempoweringhealthcareproviders,patients,andfamilieswiththeinformationandtoolstheyneedforqualitymentalhealthcare.

• Classifythemajormentaldisordersoflatelifeandcontrastthepresentationofthemajormentaldisordersoflatelifewithpresentationamongotherpatientpopulations

• Namethechiefriskfactorsassociatedwitheachofthemajormentaldisordersoflatelifeandfactorsassociatedwithoptimalmentalfunctioning

• Assessclinicalpharmacotherapyandpsychosocialtreatmentsforlate‐lifementalillnessincludingdepression,dementia,schizophrenia,delirium,bipolardisorder,Parkinson’sdisease,generalizedanxietydisorder,substanceabuse,andsleepdisorders,andapplybestpractices

• Describethreeage‐relatedchangesinpharmacologicresponseandhowthosechangesmakeeldersvulnerabletoadverseoutcomes

• Listtwopsychiatricmanifestationsofmedicaldiseases• Identifybehavioralinterventionsformanagingagitationandotherdementia‐relatedbehavioral

issuesandcitethreeevidence‐basedapplicationsthatcanbeutilizedincomplexcases• Describeonecomplementarytreatmentapproachthatcanbeutilizedinapsychosocialintervention• Identifyanethicalissuesuchasadvancedirectivesandend‐of‐lifecareandabestpracticeapproach

toresolvingthatissue• Distinguishthedeliveryofculturallyappropriatecaretospecificdiversepopulationsingeriatric

psychiatrypracticebyidentifyingtheuniquepsychosocialneedsofvariousgroupsoftheelderlypopulation

• Identifygapsinknowledgeofagingandmentalhealthandtheresearchapproachestofillthesegaps• Describetheconceptsofsuccessfulagingandqualityoflifeasrelatedtolifetransitionsandmental

status

RegistrationFees:ThefeesforthisprogramareoutlinedintheAAGPRegistrationInformation.

4  

2014AAGPAnnualMeetingScheduleofCMEEvents

Friday,March147:00AM–4:45PM DiscoverySessionW1ReviewInGeriatricPsychiatry:PreparationforSubspecialtyExaminationsProgramChair: WilliamM.McDonald,MDInformationprovidedinseparatehandout.7:30AM–12:00NOON PalaniSessionW2AAGP’S2013TrainingDirectors’WorkshopProgramChairs:SibelKlimstra,MD

ShilpaSrinivasan,MDInformationprovidedinseparatehandout.8:30AM–12:30PM GoldHall2SessionW3NeuroscienceTeachingDay:CopingwithPain:FocusonNeuroscienceofPainandPainManagementProgramChairs:MarthaPayne,PhD,RD,MPH

AdamSpira,PhDInformationprovidedinseparatehandout.Session101Beyond“StartLowandGoSlow”:WhatEveryGraduatingMedicalStudentNeedstoKnowAboutGeriatricPsychiatry1:30PM‐3:00PM AtlantisChair: SusanW.Lehmann,MDFaculty: MaryBlazek,MD DennisM.Popeo,MD WilliamB.Brooks,MDLearningObjectives:

• Describetheneedforgreaterteachingingeriatricpsychiatryformedicalstudents.• Listsixkeygeriatricpsychiatrytopicsthatallmedicalstudentsshouldbefamiliarwithbefore

graduatingfrommedicalschool.• Describetwostrategiestoenhancegeriatricpsychiatryeducationinthepsychiatryclerkship.• IdentifytworecommendationsfromtheIOM2012reportongeriatricworkforceneedsthatrelateto

medicalstudenteducation.

5  

Session102DementiaattheEndofLife1:30PM‐3:00PM CrystalEChair: JonathanT.Stewart,MDFaculty: InnaSheyner,MD,CMD BarbaraLubranodiCiccone,MDLearningObjectives:

• Discussthreemajorbarrierstohospicecareforindividualswithendstagedementia,andstrategiestoovercomethesebarriers.

• Recognizeandevaluatesymptomsofdistressinindividualswithendstagedementiaandprovideappropriatepharmacologicandnon‐pharmacologicmanagement.

• Describetheroleofthegeriatricpsychiatristinco‐managingconcurrentmedicalproblemsinendstagedementia.

• Effectivelyworkwithfamiliesofdementedindividualsonprognosticationandadvancedirectives.Session103Late‐LifeSchizophrenia:NewResearchFindings1:30PM‐3:00PM CrystalDChair: DilipV.Jeste,MD MaxL.Stek,MD,PhDFaculty: PaulMeesters,MD,PhD CarlI.Cohen,MD IpsitVahia,MDLearningObjectives:

• Participantsshouldbeabletodiscusstheimplicationsofthedifferencesincross‐sectionalandlongitudinaldataonperceivedqualityoflifeinolderadultswithschizophrenia.

• Participantsshouldbeabletoidentifyrelevantclinicalandsocialfactorsthatcanaffectperceivedqualityoflife.

• Participantsshouldbeabletoreviewhowresearchfindingsonperceivedqualityoflifemaytranslatetoimprovementintheclinicalcareofelderlypatientswithschizophrenia.

• Participantsshouldbeabletoidentifypredictorsoffunctionaloutcomeinlatelifeschizophrenia.Session104InnovativeResearchonSuicideinOlderAdults1:30PM‐3:00PM Oceans11Faculty: DimitrisN.Kiosses,PhD KatalinSzanto,MD YeatesConwell,MDDiscussant: GeorgeS.Alexopoulos,MDLearningObjectives:

• Toappreciatetheroleofsocialconnectionsinsuicideandsuicidepreventioninlaterlife.• Toidentifycorrelatesofsuicideideationinolderadultswithmajordepressionandcognitive

impairment.• Inadditiontothetraditionallyassessedclinicalriskfactors,tobeabletoassessandidentifycognitive

factorsthatcontributetosuicidalbehaviorinlatelife.• Tounderstandtheinteractiveeffectofexecutivedysfunctionwithsocialsupportonsuicideideation.

Session105StumptheChumps!TheWomanWhoCouldOnlySpeakPigLatin,andOtherOddCases1:30PM‐3:00PM Oceans12Chair: SusanS.Rose,PhDDiscussant: MaureenC.Nash,MD,MS

6  

LearningObjectives:• Describedifferentwaysinwhichpersistentdeliriumcanmimicdementia.• ListconsiderationsinthediagnosesofCreutzfeldt–Jakobdisease.• Formulateadifferentialdiagnosisforanindividualwhocanonlyspeakinpiglatin.• Discussreasonswhyapatientmaynotbeabletostopgiggling.Fordays.

Session106MovingPsychosocialInterventionstoPopulationsWithChallengingProblems3:15PM‐4:45PM AtlantisFaculty: DimitrisN.Kiosses,PhD CatherineAyers,PhD,ABPP JulieWetherell,PhD JoAnneSirey,PhDLearningObjectives:

• Attheendofthissession,participantswillbeabletodiscussthechallengesinvolvedinprovidingmentalhealthservicesinpatients'homesaspartofaninterdisciplinarymedicalteam.

• Tounderstandpreliminaryqualitativeandquantitativeresultsfromapromisingbehavioraltreatmentforolderadultswithhoardingdisorder.

• Toidentifysuccessfulcomponentsormodulesofbehavioraltreatmentforolderadultswithhoardingdisorder.

• ToidentifyrisksforrelapseforpatientswhohaveremittedafterECT.Session108TrajectoriesofRiskandSymptomExpressioninLate‐LifeDepression3:15PM‐4:45PM CrystalEChair: GeorgeNiederehe,PhDFaculty: KristineYaffe,MD HillaryR.Bogner,MD,MSCE JoyceT.Bromberger,PhDLearningObjectives:

• Describethelong‐termcourseofdepressivesymptomsinolderadults.• Attheendofthissession,participantsshouldhaveabetterunderstandingoftherelationship

betweencourseofdepressionandclinicaloutcomesincludingmortality.• Identifythemultipleriskfactorsforelevateddepressivesymptomsandmajordepressioninwomen

duringmidlifeandthemenopausaltransition.• Tounderstandhowidentifyingpatternsorcourseofdepressioncanhelpthedevelopmentand

deliveryofinterventions.Session109SayingGoodbye:AStimulusVideoDocumentaryofAttachmentandLossattheEndofLife3:15PM‐4:45PM Oceans11Chair: GeraldineFox,MD,MHPELearningObjectives:

• Describecommonpsychologicalstagesandchallengesofoldageandend‐of‐lifedecisions.• Reflectonwaystoprovideempathyandsupportwhencaringforelderlyanddyingpatients,aswell

astheirfamilies.• Reflectonourindividualexperiencesofagingandlossinourownfamiliesandcultures,andhow

theseexperiencesandbeliefsmayinformourprofessionalreactions.• Educatorswillbecomefamiliarwiththeuseofstimulusvideoandpersonalstoryinfacilitatingactive

higher‐orderlearninganddiscussion.

7  

Session110TelePsychiatry:SeamlessIntegrationinDeliveringComprehensivePsychiatricCare3:15PM‐4:45PM Oceans12Chair: JoelKirson,MDFaculty: AlexanderThrelfall,MD PaulD.S.Kirwin,MDLearningObjectives:

• UnderstandthecomponentsofsuccessfulTelePsychiatryprogramming.• Developaclearawarenessofthechallengesinprogramimplementation.• Remove'myths'aroundthelimitationsofthistechnologyinthefieldofpsychiatry.• Understandwherethenextareasofchangeinthisfieldwillmostlikelyoccurandtheimplicationsof

theseschangesonyouruseofTelePsychiatry.

Session111OpeningPlenary:BreakthroughsinScienceandBeneficenceinCare:AChargefortheAAGP5:00PM–6:30PM CrystalABCFaculty: SusanK.Schultz,MD

8  

Saturday,March15,2014ISS1MatureMoodMatters:NewandEmergingDevelopmentsinGeriatricDepression7:30AM–9:30AM CrystalABCSupportedbyaneducationalgrantfromLundbeckandTakedaPharmaceuticalsU.S.A.,Inc.Chair: J.CraigNelson,MDFaculty: DavidC.Steffens,MDInformationprovidedinseparatehandout.Session201IntensiveBehavioralManagementinLong‐TermCareSettingsUsinganAppliedBehaviorAnalysis(ABA)Approach9:45AM‐11:15AM AtlantisChair: MarcE.Agronin,MDFaculty: BarbaraSparacino,MD LeilaniFeliciano,PhDLearningObjectives:

• Reviewthecurrentneedforbehavioralapproachesinlong‐termcare,andtheavailablemodalities.• ReviewthebasicprinciplesofAppliedBehaviorAnalysis(ABA).• DiscusstheuseofABAwithbehavioralandpsychologicalsymptomsofdementia.• DiscusstheimplementationofanABAapproachatMiamiJewishHealthSystems,Florida'slargest

long‐termcarecenter.Session202OptimizingDepressionCareandTreatmentforRecipientsofHome‐basedServices9:45AM‐11:15AM CrystalEChair: YolondaPickett,MD,MSFaculty: KishaN.Bazelais,PhD JoAnneSirey,PhD MarthaL.Bruce,PhD,MPHLearningObjectives:

• Participantsshouldbeabletorecognizetheriskofvulnerabilityofolderhomeboundadultsacrossfourdomains:nutrition,disability,mentalhealthandphysicalhealth.

• Participatesshouldunderstandracialandethnicdifferencesinratesoftreatmentofgeriatricdepressioninthehomebound.

• Participantsshouldunderstandhowengagementinhome‐basedservicecanimprovetreatmentinotherwiseundetecteddepression.

• Participantsshouldunderstandhowcollaborativemodelswithhome‐basedagenciesareusedtoimprovetherecognitionandtreatmentofdepressioninolderadults.

Session203UpdateonGeriatricSleepDisorders9:45AM‐11:15AM CrystalDChair: WilliamM.McDonald,MDFaculty: WilliamV.McCall,MD,MS AndrewNamen,MD DonaldL.Bliwise,PhDLearningObjectives:

• Theattendeewillunderstandthecommoncausesofinsomniaintheelderly.• Theattendeewillunderstandthemostsafeandeffectivetreatmentsofinsomniaintheelderly.

9  

• Theattendeewillunderstandtheclinicalpresentationofsleepapneaintheelderly.• Theattendeewillunderstandthesleepdisordersassociatedwithdementia.

Session204ImplementationofIntegratedCollaborativeGeriatricMentalHealthCareModels:WhatHaveweLearnedfromaDecadeofExperience?9:45AM‐11:15AM Oceans11Chair: JoelE.Streim,MDFaculty: MalazBoustani,MD,MPH JurgenUnutzer,MD,MPH,MA DavidW.Oslin,MDLearningObjectives:

• Describeatleastthreekeyelementsthatleadtosuccessfulimplementationofcollaborativecareprograms.

• Identifyatleastthreechallengesforimplementationofcollaborativecareprograms,anddiscussapproachestomanagingbarriers.

• Recognizethevalueofmeasurementforlearningaboutprogrameffectivenessasabasisforprogrammodificationsandcontinuousimprovement.

• Understandhowimplementationofcollaborativecareprogramshascontributedtothepastdecadeofhealthcarereform.

Session205ToUseorNottoUse:ThatistheQuestionforCliniciansPrescribingDementiaDrugs.AClinician'sDebate9:45AM‐11:15AM Oceans12Chair: IstvanJ.Boksay,MD,PhDFaculty: MaureenC.Nash,MD,MS SandraS.Swantek,MDLearningObjectives:

• Detailthreereasonstousedementiaspecificmedications.• Detailthreereasonsnottousedementiaspecificmedications.• Understandhowcliniciansreasonthroughthedecisionmakingprocessregardingmedicationuses.• Participantswillbeabletodiscussboththeprosandconsoftheuseofcholinesteraseinhibitorsin

thetreatmentofAlzheimer'sdementia.Session206CasePresentationSession19:45AM‐11:15AM Odyssey‘MyDaughterisHangingfromaPlantPot’:ACaseofLewyBodyDementiaFaculty: SarahBrunelle,MDLearningObjectives:

• TounderstandthemanifestationsanddiagnosticcriteriaofLBD.• TodiscussthetreatmentofLBD,withaparticularattentiontotheindicationsandassociated

risks.ACaseStudyRevealingtheComplicationsinDiagnosingFrontotemporalDementia,BehavioralVariantFaculty: UmaSuryadevara,MD

10  

LearningObjectives:• Lookatthebiggerpictureanddonotforgettouseclinicaldiagnosticcriteria/simplehistorytaking

skills.Itmightgiveusmoreinformationwhichcouldbemissedifwerelyonlyondiagnosticmethods.

• Tounderstandthepsychosocialimplicationsofamisseddiagnosisforthepatientandtheirfamilymembers/caregivers.

76‐year‐oldMalewithProgressiveSpeechImpairmentandRelatedCognitiveDeclineFaculty: ShujaHaque,MDLearningObjectives:

• Participantswillbeabletoidentifychallengesintheassessmentanddiagnosisofpatientswhopresentwithatypicaldementias.

• Participantswillbeabletorecognizecasesofdementiasthatpresentwithpredominantspeechimpairment.

ISS2ChallengesofObtaininganEarlyandAccurateDiagnosisofAlzheimer’sDisease:WhatistheRoleofAmyloid‐PETImaging?12:45PM–2:45PM CrystalABCSupportedbyaneducationalgrantfromLillyUSA,LLCChair: GarySmall,MDFaculty: RanjanDuara,MD,FAAN SuzeeLee,MDInformationprovidedinseparatehandout.Session207PlenarySession:FindingsfromtheCoalitiononMentalHealthandViolence11:30AM‐12:30PM DiscoveryFaculty: PaulD.S.Kirwin,MD DilipJeste,MD JeremyLazarus,MDLearningObjectives:

• TobetterdefineanddelineatetheinteractionofMentalHealthandviolance• Increasepublicawarenessabouttheroleofmentalhealthandviolance,includingtheriskofsuicide.• Promotediscussionaroundguidlinesforhealthprofessionalstodealwiththepossesionoffirearms

bypatients.Session208DelusionalDepressioninLateLife:TreatmentEffectsonMood,Psychosis,CognitionandtheBrain3:00PM‐4:30PM AtlantisChair: BarnettS.Meyers,MDFaculty: BenoitH.Mulsant,MD,MS,FRCPC EllenM.Whyte,MDLearningObjectives:

• SymposiumparticipantswillbeabletodescribetherationalefortheSTOPPDIandIIstudies.• Symposiumparticipantswillbeabletodescribetheresponsetotreatmentofolderadultsintermsof

resolutionofdepressionanddelusions.• Symposiumparticipantswillbeabletodescribetherelationshipbetweencognitivestatusand

treatmentresponseamongolderadultswithdelusionaldepression.• Symposiumparticipantswillbeabletodescribepossibleeffectsofantipsychoticmedicationson

brainstructure.

11  

Session209IntensiveTeamTrainingtoMeettheNeedsofDementiaPatients:PositiveCareSkillsandRoutinesthatCanHelp3:00PM‐4:30PM CrystalEChair: HelenH.Kyomen,MDFaculty: TeepaL.Snow,MD,OTR/LLearningObjectives:

• Describetypicalresistiveandchallengingbehaviorsthatoccurduringcareeffortsandinteractionsasdementiaprogresses.

• Discusssixmajorcomponentsthatmustbeconsideredininvestigatingandtryingtohelpwithresistiveorchallengingbehaviors.

• Developaproblemsolvingstrategytoevaluateandmanageresistiveorchallengingbehaviorsindementiapatients.

• Rehearsetheuseofaproblemsolvingstrategytoassessandintervenewhenresistiveorchallengingbehaviorsareidentifiedinsimulatedcases.

Session210UnderstandingPsychosisinParkinson'sDisease3:00PM‐4:30PM DiscoveryBRChair:WilliamM.McDonald,MDFaculty: LauraMarsh,MD DanielWeintraub,MDLearningObjectives:

• TheattendeewillunderstandtheimpactofthemedicationsusedtotreatthemotorsymptomsofPDonpsychiatricsymptoms.

• TheattendeewillunderstandtheepidemiologyofpsychoticandotherpsychiatricsymptomsinPD.• Theattendeewillunderstandtheevidenced‐basedtreatmentofpsychiatricsymptomsinPD.• TheattendeewillunderstandhowtodistinguishPDwithdementiaforDLB.

Session211Cognition,BiomarkersandOutcomesinGeriatricMoodDisorders3:00PM‐4:30PM CrystalDChair: KirstenWilkins,MDFaculty: JenniferGatchel,MD,PhD PaulBlackburn,MD LaurMarrone,MDSession212Cognition,BiomarkersandOutcomesinGeriatricMoodDisorders3:00PM‐4:30PM Oceans11Chair: HelenLavretsky,MDFaculty: HowardAizenstein,MD RuthO'Hara,PhD GeorgeS.Alexopoulos,MDLearningObjectives:

• TheparticipantswilllearntorecognizetherelationshipbetweenstructuralandfunctionalMRImarkers(graymattervolume,WMHburden,meandiffusivity,andfractionalanisotropy)andtreatmentresponseingeriatricdepression.

• Theparticipantswilllearnbraincircuitsinvolvedincognitivecontrolthathelpdistinguishlate–lifeapathyfromdepressionandpredictexecutivedysfunctionandtreatmentresponse.

• TheparticipantswilllearnbraincircuitsinvolvedinemotionalregulationusingfMRIemotionalconflictresolutiontasksaspredictorofcognitiveandtreatmentoutcomes.

12  

• Theparticipantswilllearnaboutcognitivepredictorsofoutcomesifromageriatricdepressiontrialusingmethylphenidateaugmentationofcitalopram.

Session213ELECTION2014:TheStakesforMentalHealthandAgingAdvocates3:00PM‐4:30PM Oceans12Chair: IlseR.Wiechers,MD,MPPFaculty: DavidWasserman,MALearningObjectives:

• Discusstheoutlookforthe2014Congressionalmidtermelectionsandtherolethathealth,mentalhealth,andagingissuesmightplayinthoseelections.

• Discusstheenvironmentthatshapesthe2014Congressionalelectionandciteissuesthatwillbemostimportanttovotersinthoseelections.

• IdentifywaysthatgeriatricpsychiatristscanhelptoshapepublicpolicythroughinvolvementwithcandidatesforFederalofficeandwillbeabletoutilizethosestrategies.

• IdentifywaysthatgeriatricpsychiatristscanhelptoshapepublicpolicythroughinvolvementwithcandidatesforFederalofficeandwillbeabletoutilizethosestrategies.

Session214CasePresentationSession23:00PM‐4:30PM OdysseyToBeorNottoBe:DialysisDiscontinuationandDepressionintheElderlyFaculty: ShrutiMutalik,MDLearningObjectives:

• Tobeabletoassesselderlypatientsrefusingdialysis,takingintoconsiderationthecognitive,affective,existential,ethicalandfunctionalcontextofthisdecision.

• Toappreciatedialysisintheframeworkofpalliativecareandtohelpandbetterinformpatientsintheirdecisionmakingregardingtheinitiationanddiscontinuationofdialysis.

MultidisciplinaryApproachtoTreatmentofComorbiditiesFaculty: MarianneBergheim,MDLearningObjectives:

• Reviewmedicaletiologiesthatmaycontributetopresentationofpsychiatricsymptoms.• Recognizethevalueofamultidisciplinarytreatmentapproachinthefaceofmedicalco‐morbidities.

APalliativeCareRotationforGeneralPsychiatryResidents:NewHorizonsinPsychiatricResidencyTrainingFaculty: AndrewN.Dentino,MD,FAPALearningObjectives:

• Forattendeestobecomeapprisedandtobeinvitedtoformtheirownacademic/professionalopinionsastothepossibleimportanceforpsychiatryresidentstohaveexperiencesinHPM,tobecomesensitizedastothepersonalexperiencesandemotionsofapsychiatryresidentinundertakingthislearningactivity,andtothepossibleacademicandpersonalbenefitsfortheresidentinherorhispersonalacademicmaturationandfuturecareerdevelopment.

• Forattendeestobecomeapprisedofthepossibilitiesoftheparadigmofpalliativepsychiatrytorepresentabonafidecareerpathforafuturepsychiatrist,tobecomeawareofthepossibilitiesforcreatingeducationalexperienceswithinthepsychiatryresidencytoteachthisparadigm,andforthespecialtyofpsychiatrytohaveauniqueandlearnedvoiceinthefuturenationaldiscussionsoftheroleofHPMinournation'shealthcare.

13  

Session215CaringforVulnerableElders:ClinicalCollaborationswithAdultProtectiveServices4:45PM‐6:15PM AtlantisChair: JasonE.Schillerstrom,MDFaculty: ElizabethJ.Santos,MD KellyL.Dunn,MDLearningObjectives:

• Theaudiencewillbeabletodescribetheepidemiologyofelderabuse,neglect,andexploitation.• Theaudiencewillbeabletodiscusstherelationshipbetweencognition,selfcareabilities,and

decisionalcapacityinAPSclients.• TheaudiencewillbeabletodescribetheneedsofAPScaseworkersfromgeriatricpsychiatristsin

thecommunityandinacademia.• Theaudiencewillbeabletodescribehowtoeffectivelyworkwithsurvivorsofelderphysicaland

sexualabuse.Session216MockTrialofaLawsuitAllegingFinancialFraudAgainsta79‐Year‐OldWomanbyanInsuranceAgentandanInsuranceCompany4:45PM‐6:15PM CrystalDChair: ElliottM.Stein,MDFaculty: SanfordI.Finkel,MD BenjaminLiptzin,MD BarryReisberg,MD JayLuxenberg,MDLearningObjectives:

• Attheendofthissession,participantsshouldbeabletounderstandthestructureofacourtproceeding.

• Attheendofthissession,participantsshouldhaveabetterunderstandingofissuesoffinancialcapacityintheelderly.

• Attheendofthissession,participantsshouldbebetterabletorespondtoquestionsfromattorneys.• Attheendofthissession,participantsshouldbebetterabletoconsultonlegalmatters.

14  

Sunday,March16,2014Session301DevelopingYourResearchCareer8:00AM–10:00AM PalaniChair: OliviaOkereke,MD,MSLearningObjectives:

• Identifytwocomponentsofagrantapplicationthatarecriticaltosuccess• Describethreestrategiesinanearlyacademiccareerthatcontributetoasuccessfulresearch

career• DiscussthecurrentprioritiesoftheNIMH

Session302EmotionRegulationinLate‐LifeDepression:NeuralModelstoTreatmentStrategies9:45AM‐11:15AM AtlantisChair: MoriaSmoski,PHDFaculty: WarrenD.Taylor,MD,MHSc PatriciaA.Arean,PhD DavidC.Steffens,MD,MHSLearningObjectives:

• Attheendofthissession,participantsshouldbeabletodescribehowdeficitsinemotionregulationrelatetomajordepressivedisorder.

• Attheendofthissession,participantsshouldbeabletounderstandtheneuralcircuitrythatsupportsemotionregulation,aswellashowvasculardiseaseandvolumetricchangesinfrontal,limbic,andsubcorticalregionsimpactregulation.

• Attheendofthesession,participantsshouldbeabletodescribeconsciousemotionregulationstrategies,includingreappraisalanddistraction.

• Attheendofthesession,participantsshouldbeabletodescribehowcognitivecontroldeficitsimpactemotionregulationandinterventionoutcomes.

Session303IntegratingNeuroimagingintoClinicalTrials:Opportunities&Challenges9:45AM‐11:15AM CrystalEChair: JovierEvans,PhDFaculty: HowardAizenstein,MD GeorgiosPetrides,MD FaithM.Gunning‐Dixon,PhDLearningObjectives:

• AttheendofthesessiontheaudiencewillbefamiliarwiththecurrentknowledgeabouttheeffectsofElectroconvulsiveTherapyonrestingstatefMRIinpatientstreatedfordepression.TheyshouldbeabletorecognizechangesafterECTintheDefaultN.

• AttheendofthesessionparticipantsshouldbeabletoidentifytheprimaryMRimagingmarkersshowntopredictdepressiontreatmentresponse.

• AttheendofthesessionparticipantsshouldbeabletoidentifytheprimaryMRimagingmarkersshowntoberelatedtopoorcognitivecontrol.

• Attheendofthesessionparticipantsshouldrecognizetheprimaryresting‐statefunctionalbrainnetworks.

15  

Session304AddressingSexandSexualitywithOlderAdults:AnOpportunitytoLearnandPracticeEffectiveCommunicationTechniques9:45AM‐11:15AM CrystalDChair: DennisM.Popeo,MDFaculty: DanielD.Sewell,MD KevinK.JohnsonDiscussant: JanetM.Abrams,MSWLearningObjectives:

• Describeastrategyforaskingolderadultsabouttheirsexlifeandlistseveralspecificquestionstoaskanolderpatienttoassesstheirsexualityandsexlife.

• FormulateanapproachtoasexualinterviewofolderLGBTadults.• Employthetacticsandskillslearnedinthesymposiumduringaroleplayexerciseandappraise

theirperformanceattheroleplay.• Synthesizetheskillslearnedforutilizationintheirpractice.

Session305TheExamStartsintheHallway:MovementDisordersinGeriatricPsychiatry9:45AM‐11:15AM Oceans11Chair: LauraMarsh,MDFaculty: WilliamM.McDonald,MD NikolausMcFarland,MD,PhD SarahFayad,MDLearningObjectives:

• TheattendeewillunderstandtheepidemiologyofParkinson’sdiseaseandrelateddisordersanddrug‐inducedmovementdisordersingeriatricpsychiatrypatients.

• Theattendeewillidentifythecausesandcharacteristicsofdrug‐inducedmovementabnormalities.

• Theattendeewilldescribethedistinguishingclinicalfeaturesofthevariousparkinsoniansyndromes.

• Theattendeewillidentifytreatmentsforpsychiatricdisturbancesassociatedwithatypicalparkinsoniansyndromes.

Session306EarlyExperienceswithImplementationofAccountableCareOrganizations(ACOs):HowareGeriatricMentalHealthServicesProvided?9:45AM‐11:15AM Oceans12Chair: JoelE.Streim,MDFaculty: BenjaminLiptzin,MD HenryChung,MD JulesRosen,MDLearningObjectives:

• DescribeatleastthreekeyelementsthatdefineanACO.• Understandtheconceptofsharingriskforadefinedpopulationofpatients.• Recognizetherangeofoptionsforintegratingmentalhealthcarewithinprimarycare.• Describeatleastthreedifferentarrangementsbywhichgeneralandgeriatricpsychiatristsand

othermentalhealthproviderscanbepaidfortheirworkwithanACO.

16  

Session307CasePresentationSession39:45AM‐11:15AM OdysseyTheDilemmaContinues:DistinguishingDepressionandDeliriumFaculty: JacquelineDecker,DOLearningObjectives:

• Overlapofsymptomsbetweenhypoactivedeliriumanddepressionandtheimportanceoftreatmentofdelirium.

• Theefficacyofantidepressantsinthetreatmentofmooddisordersduetohypothyroidism.70‐Year‐OldMalewithPrimaryProgressiveAphasiaFaculty: AdharshSahadevan,MD,MPHLearningObjectives:

• Participantswillbeabletodiagnosecasesofdementiathatpresentwithprimaryspeechimpairment.

• Participantswillbeabletomanagecasesofdementiathatpresentwithprimaryspeechimpairment.

PsychosisofNeurosyphilisinaChineseImmigrantFaculty: ArnabhBasu,MBBSLearningObjectives:

• Writersdrawattentiontoworldwideincreaseinincidenceofsyphilis,primarilyinurbanareas,highlightinginfluxofmigrantpopulationsasapossiblecontributor,especiallyco‐morbidwithHIVinfection.

• Thoughrare,neuropsychiatricmanifestationsofsyphilismustremainasadifferentialofpatientwithnoknownpastpsychiatrichistorywithrecentonsetofpersonalitychanges,behavioral,cognitiveandperceptualdisturbances.

Session308PlenarySession:FeaturingMentalHealthAdvocateKathyCronkiteSponsoredinpartbyaneducationalgrantfromLillyUSA,LLC.SupportedinpartbytheGeriatricMentalHealthFoundation.11:30AM‐12:30PM DiscoveryFaculty: KathyCronkiteLearningObjectives:

Describetheimpactofdepressiononindivididualsinthepubliceyeandtheirfamilies Listthewaysinwhichdepressioncanmanifestitselfoverthedecadesofone’slife Describetwowaystoraisepublicawarenessofdepressionandthetreatmentandprofessionals

availabletohelpSession309TheGeriatricPsychiatristasFamilyCaregiver:LessonsLearned1:30PM‐3:00PM AtlantisChair: BenjaminLiptzin,MDFaculty: JoelE.Streim,MD ChristopherC.Colenda,MD,MPHLearningObjectives:

• Learntoassessfamilymembersforcognitive,physical,oremotionalproblems.• Learnhowtoaddresstheconcernsdirectlywiththeolderrelative.• Learnhowtoaccessandmanageresourcesforanolderrelative.

17  

• Learnhowtorespecttheperson'sautonomywhilekeepingthemsafeandfunctioningattheirmaximumlevel.

Session310DiverseInternationalApproachestoOnlineEducationinGeriatricPsychiatry1:30PM‐3:00PM CrystalEChair: MarkJ.Rapoport,MD,FRCPCFaculty: TimothyE.Lau,MD,FRCPC,MSC MelindaS.Lantz,MD DamienGallagher,MB,MD,MRCPsychLearningObjectives:

• Todiscoverhowelectronicmedia,informationandcommunicationtechnologies,augmentblendedinterdisciplinarylearninginundergraduateeducation.

• Tounderstandhowonlinelearningmediamaycomplementexistinglearningmethodsforresidentsinpsychiatry.

• Todescribethechallengesandopportunitiesavailableinusingonlineactivitiestoenhance,facilitateandassistcontinuingmedicaleducationandmaintenanceofcertificationforpracticingpsychiatrists.

• Tounderstandtheconceptof“engagement”inonlinelearning.Session311OntheMove:Home‐BasedExperiencesandEducationalMilestonesinGeriatricPsychiatryFellowship1:30PM‐3:00PM CrystalDChair: SusanM.Maixner,MDFaculty: RandallEspinoza,MD,MPH SandraS.Swantek,MDLearningObjectives:

• Theparticipantwilldefinehomevisitsingeriatricpsychiatrytraining.• Theparticipantcandiscussthedevelopmentofrelevantmilestonesforexistingornewlycreated

homevisitexperiencesforgeriatricpsychiatryfellows.• Theparticipantwillrecognizethevarietyofhomevisitoptionsavailabletotrainees.• Theparticipantwilldiscusschallengesinimplementinghomevisits,andstrategiestoovercome

these.Session312CognitionandFunctioninginOlderPatientswithSchizophrenia:RecentResearch1:30PM‐3:00PM DiscoveryBRChair: JohnKasckow,MD,PhDFaculty: CarlI.Cohen,MD TarekRajji,MDDiscussant: PhilipD.Harvey,PhDLearningObjectives:

• Developabetterunderstandingofthecourseofeverydayfunctioninginolderpatientswithschizophreniacurrentlylivinginthecommunity.

• Understandaboutchangesincognitionandfunctionalskillsthatareassociatedwiththesechangesineverydayfunctioning.

• Understandhowwellolderindividualscanparticipateintelehealthinterventions.• Todiscusstheimplicationsofthedifferencesincross‐sectionalandlongitudinaldataof

neurocognitivestatusinolderadultswithschizophrenia.

18  

Session313InnovativeModelsofGeriatricMentalHealthServicesinLong‐TermCare1:30PM‐3:00PM Oceans11Chair: AllanA.Anderson,MDFaculty: LeoJ.Borrell,MD JunjiTakeshita,MDLearningObjectives:

• TheattendeewillidentifyseveralmodelsofprovidingclinicalgeriatricmentalhealthcaretoLTCresidents.

• Theattendeewillbeabletoidentifyappropriatemeanstoobtainadditionalfinancialreimbursement,outsideofbillingfordirectcare,toensurethatsuchmodelsarefinanciallyviable.

• TheattendeewillbeabletodiscusssomeofthebarrierstoprovidinggeriatricmentalhealthservicesinLTC.

• TheattendeewillbeabletoidentifywaystoovercomesomeofthebarrierstoprovidinggeriatricmentalhealthservicesinLTC.

Session314EmergingModelsofPsychiatricServicesinaPioneerAccountableCareOrganization:PersonalReflectionsofPsychiatristsontheFrontLine1:30PM‐3:00PM Oceans12Chair: GaryJ.Kennedy,MDFaculty: SallyRicketts,MD MirnovaE.Ceïde,MD PaulaMarcus,MDLearningObjectives:

• BeabletoidentifyonecriticalsocialcomponentofsuccessintheDedicatedModelsofcare.• Describeoneexampleofhowthepsychiatristaddressestheconflictbetweenthepatient

centeredethicofpersonalautonomyandthepublichealthimperativeofthegreatestgoodforthegreatestnumber.

• Identifythe3overarchinggoalsofAccountableCareOrganizations.• Describeoneexampleofimprovedqualityandoneofimprovedcostofcarethataretargetsof

themodelspresented.Session316TrainingPsychiatryResidentsandFellowsinQualityImprovement:GeriatricPsychiatryCanHelpLeadtheWay3:15PM‐4:45PM AtlantisChair: GaryEpstein‐Lubow,MDFaculty: RobertJ.Boland,MD JosephaA.Cheong,MD MariaLlorente,MDLearningObjectives:

• Participantswillbeabletodescribethecoreprinciplesofqualityimprovement.• Participantsshouldbeabletoreportonthepublisheddescriptionsofmodelsforteachingquality

improvementtoresidentsinpsychiatry.• Participantswillbeabletoexplaintheprocessofdevelopingaqualityimprovementcurriculum

tailoredtoaspecificinstitutionorresidencytraining.• Participantswillbeabletolistpotentialbarrierstosuccesswithqualityimprovement

curriculum,andstrategiestoovercomebarriers.

19  

Session317SeniorInvestigatorWorkshopontheNewNIHPoliciesforResearchFundingandProgramOpportunities3:15PM‐4:45PM Oceans11Chair: HelenLavretsky,MDFaculty: MollyV.Wagster,PhD JovierEvans,PhDDiscussant: GeorgeNiederehe,PhDLearningObjectives:

• ParticipantswillbeabletolearnanddiscussthenewdevelopmentsinfundingprioritiesinresearchattheNIMHandNIA.

• ParticipantswillbeabletodiscussnewtrendsinnovelinterventiondevelopmentsupportedbyvariousNIHprograms.

• ToreviewtheongoingprogrammatictransitionsprogramdevelopmentsandfundingopportunitieswithintheNIMHandNIAimportantforseniorinvestigators.Inadditionallavailablefundingopportunities,includinganypossiblerelevantRAFsoropportunitiesmadeavailablethroughtheNIHCommonFundorNeuroscienceBluepring;RDOCwillbediscussed.

• Toreviewthemainprinciplesofgrantapplications.Session318UpdateonEvidenced‐BasedPracticeinECT3:15PM‐4:45PM Oceans12Chair: WilliamM.McDonald,MDFaculty: RobertM.Greenberg,MD CharlesH.Kellner,MDDiscussant: GeorgiosPetrides,MDLearningObjectives:

• TheattendeewillunderstandtheevidenceassociatedwiththeefficacyandsafetyofultrabriefpulseECT.

• Theattendeewillunderstandtherisksandbenefitsofthethreecommonelectrodeplacementsinolderpatients.

• Theattendeewillunderstandthestepstotakeifthereisamissedorshortseizure.• Theattendeewillunderstandhowtomanagepostictalagitation.

Session320CreativeResilience&Aging:LouisArmstrong,Race,&GrowingOldinthe60s5:00PM‐6:30PM CrystalEChair:JeffreyM.Lyness,MDLearningObjectives:

• TheparticipantwillunderstandLouisArmstrong’sartisticworksofhislateryearsinthecontextofhispersonalandprofessionalbiography,andwillbeabletodiscusstheprominentthemesthatemergefromconsiderationoftheseworks.

• Theparticipantwillbroadenher/hisknowledgeof,andappreciationfor,artisticexpressioninlaterlifeanditscontributiontohealthyagingandresilience.

• Theparticipantwillbeabletodiscusshowchangingculturalperceptionsofacceptableordesirablebehaviorsmayaffectthedegreetowhicholderadultsfeelconnectedtoorisolatedfromsociety.

• Theparticipantwillbeabletodiscusstheimplicationsoftheseissuesforclinicalworkwitholderadultsandtheirfamilymembers.

20  

Session321HospiceExperienceinGeriatricPsychiatryFellowshipTraining:AMulti‐DisciplinaryApproachtoEthicalDilemmas5:00PM‐6:30PM CrystalDChair: ShilpaSrinivasan,MDFaculty: JamesG.Bouknight,MD,PhD JulietA.Glover,MD SharonSalley,MSWLearningObjectives:

• Sessionattendeeswillrecognizetheroleofgeriatricpsychiatryinhospicecare.• Sessionattendeeswillbecomefamiliarwiththedemographicchangesoverthenext20years

thatmakeHospiceanincreasinglynecessarypartofpatientcare.• SessionattendeeswillunderstandtheroleoffamilydynamicsinEndofLifeCare.• Sessionattendeeswillidentifytheinter‐disciplinarycomponentsofaneffectiveHospice

TreatmentTeam.Session322CasePresentationSession45:00PM‐6:30PM OdysseyToGiveorNottoGive:ChallengesofLong‐TermBenzodiazepineUseinOlderAdultsFaculty: IsisBurgos‐Chapman,MDLearningObjectives:

• Discusshowharmreductiontechniquescouldbeappliedtoindividualswithtendenciestoself‐medicate.

• Identifyusefulnessofdiscussingwitholderpatientsconcernsregardingpotentiallongtermeffectsofbenzodiazepines.

ConnectingtheDots:ACaseofShyDragerSyndrome(MSA‐C)Faculty: AdrianaSofiaP.Perilla,MALearningObjectives:

• Emphasizeimportanceofintegratingmultipleobservations,assessmentsandtreatmentsfromavarietyofdisciplinesanddoacomprehensiveassessment.

• Givemoreimportancetocloselymonitoringwhatappearstobeoutofcontextoratypicalsymptoms,signs,presentationsandfollowcloselythedevelopmentandcourseofthosesymptomsoveratimeperiod.

LithiumRe‐ChallengeinaMedicallyComplicatedPatientwithLongstandingHistoryofBipolarDisorderTypeIFollowingRenalFailureandKidneyTransplantation:AgingwithBipolarDisorderFaculty: EricaC.Garcia‐Pittman,MDLearningObjectives:

• Reviewoftheagingkidneyincludingphysiologicalchanges.• LiteraturereviewofLithium‐inducerenaldisease.

21  

Monday,March17Session401FrailtyandDepressioninLateLife:Phenomenology,Prognosis,andPathophysiology9:45AM‐11:15AM AtlantisChair: PatrickBrown,PhDFaculty: BrianaMezuk,PhD JenniferFelger,PhDDiscussant: StevenRoose,MDLearningObjectives:

• Participantsshouldbeableto:identifythespecificcharacteristicsofthesyndromeoffrailty.• Distinguishbetweenthesyndromeoffrailtyandlatelifedepression.• Understandtheincreasedriskthatthedepressed‐frailphenotypepossesonprognosis.• Understandthenatureoftherelationshipbetweenlatelifedepression,inflammation,andthe

syndromeoffrailtyanditsimpactonantidepressanttreatmentresponse.Session402PsychotherapyInLateLife9:45AM‐11:15AM CrystalEChair: AlexanderThrelfall,MDFaculty: DavidW.Oslin,MD JeremyDoughan,PsyD PatriciaA.Arean,PhDLearningObjectives:

• Understandthecurrentstatusofworkforceshortagesinprovidingevidencedbasedpsychotherapiesinlate‐life.

• Learnhowtoidentifyanddiagnosedepression,anxietyand/orsubstanceabuseinlate‐life.• Understandcognitive,cultural,andmedicalfactorsinlate‐lifethatfunctionaspredictive

measuresofoutcomeintheuseofpsychotherapyforlate‐lifemood,anxietyandsubstanceabusedisorders.

• Recognizewhichpsychotherapiesinlate‐lifearemostappropriateandgainanappreciationofthekeyelementsinthesepsychotherapiesthataidinthepositiveoutcomesoftreatment.

Session403PhysicianandAdvancedPracticeNurseCollaborationinCaringfortheMentalHealthNeedsoftheElderly9:45AM‐11:15AM CrystalDChair: EllenM.Whyte,MDFaculty: MelodeeL.Harris,APNDiscussant: EveHeemanByrd,MSNLearningObjectives:

• Symposiumparticipantswillbeabletoexplainthevariededucationalpathwaysavailablethatleadtoadvancednursepractice(APRN).

• SymposiumparticipantswillbeabletodiscussthevariabilityofscopeofpracticeforAPNsthatvarybasedoneducationalbackgroundandStateinwhichlicensingisobtained.

• SymposiumparticipantswillbeabletodescribetwomodelsofAPNpracticeincludingtheroleofthepsychiatristineachmodel.

• Symposiumparticipantswillbeabletodescribeongoinginitiativesinnursingeducationwhichwillleadtoincreasedtrainingopportunitiesingeriatricsandgeriatricmentalhealth.

22  

Session404ASystematicApproachtothePharmacotherapyofLate‐LifeMentalDisorders9:45AM‐11:15AM OdysseyChair: BenoitH.Mulsant,MD,MS,FRCPCFaculty: EricLenze,MD TarekRajji,MDLearningObjectives:

• Attheconclusionofthislecture,participantsshouldbeabletoidentifythefactorsassociatedwithpoortreatmentoutcomesunderusualcareconditions.

• Attheconclusionofthislecture,participantsshouldbeabletomaximizetheeffectivenessofpharmacotherapyforlate‐lifedepression.

• theconclusionofthislecture,theparticipantsshouldbeabletomaximizetheeffectivenessofpharmacotherapyforlate‐lifeanxietydisorders.

• Attheconclusionofthislecture,participantsshouldbeabletomaximizetheeffectivenessofpharmacotherapyforagitationoraggressionassociatedwithdementia.

Session405ElectroconvulsiveTherapyasaTreatmentfortheBehavioralDisturbancesofDementia11:30AM‐1:00PM AtlantisChair: BrentForester,MDFaculty: ShawnM.McClintock,PhD,MSCS SteveSeiner,MD DeepaAcharya,PhDLearningObjectives:

• Toidentifyproblembehaviorsindementiaandhowthesebehaviorsimpactqualityoflife,healthcarecostsandrateofinstitutionalization.

• Toassessthebenefitsandlimitationsofpharmacologicalinterventionsforagitationandaggressioninpatientswithdementia.

• Todiscusstheneurocognitiveeffectsofelectroconvulsivetherapyingeriatricpatients.• Toevaluatetheutilityofelectroconvulsivetherapyasatreatmentforagitationandaggressionin

dementia.Session406TheClinicalManagementofLate‐LifeDepression:ImplicationsforSignalDetectionandTreatmentOutcome11:30AM‐1:00PM CrystalEChair: BretR.Rutherford,MDFaculty: MarkMiller,MD J.CraigNelson,MDDiscussant: StevenRoose,MDLearningObjectives:

• Attheendofthissymposium,participantsshouldbefamiliarwiththeproblemposedbyhighandrisingplaceboresponsetoantidepressantclinicaltrials.

• Attheendofthissymposium,participantsshouldbeabletodescribe2majorsourcesofplaceboresponseduringantidepressanttreatment.

• Attheendofthissymposium,participantsshouldbefamiliarwiththeuniquechallengestotreatingolderpatientsthatmaycausesuchindividualstobenefitfrommoreintensiveclinicalmanagement.

• Attheendofthissymposium,participantsshouldbeabletoconsidercostsandbenefitstomorevs.lessintensiveclinicalmanagementstrategiesindifferenttreatmentsettings(researchvs.clinical).

23  

Session407ModifiableRiskFactorsforNeurodegeneration11:30AM‐1:00PM CrystalDChair: DavangereP.Devanand,MDFaculty: GarySmall,MD DavidA.Merrill,MD,PhD JoseA.Luchsinger,MD,MPHLearningObjectives:

• Becomeawareoftheconnectionbetweentraumaticbraininjuryandaccumulationofbraintau.• Understandhowexercisebehaviorsimpactmemoryandbrainhealthandhowphysicianscan

engagepatientsonthisissue.• Recognizetheroleofdiabetesandinsulinresistanceinthedevelopmentofdementia.• Understandtherolesofantidepressantmedicationandcognitiveenhancertreatmentinpatients

withcomorbiddepressionandcognitiveimpairment.Session408PrisonerofHerPast:TheLastingEffectsofTraumainLateLife11:30AM‐1:00PM DiscoveryBRChair: MarcE.Agronin,MDDiscussant: HowardReichLearningObjectives:

• Learnaboutcurrentknowledgeaboutlate‐lifePTSD.• WatchthedocumentaryPrisonerofHerPast.• DiscussthedocumentarywithHowardReichandMarcAgronin,MD.• Discusstheelementsoflate‐lifePTSDevidentinthedocumentary.

Session409Novel‐mechanismTreatmentDevelopmentforLate‐LifeDepressionandAnxietyDisorders:NewMedicationsandNewMethods11:30AM‐1:00PM OdysseyChair: EricLenze,MDFaculty: DanielBlumberger,MD,MSc,FRCPC JordanF.Karp,MDLearningObjectives:

• Identifypotentialreasonsfordrugdiscoveryfailures.• UnderstandtherationaleforopioidergictreatmentsinLL‐TRD.• Understandtherationaleforantiglucocorticoidtherapyinlate‐lifeanxietydisorders.• Understandtheroleoftranslationalneurosciencebiomarkers,particularlytheemergingnovel

methodsofTMS‐EEG,inearly‐phasetreatmentdevelopment.

24  

AAGP’SPOLICIESONCONFLICTOFINTERESTDISCLOSUREAsaCMEprovider,AAGPhasproceduresinplacetoensurethatactivitiesareplannedandpresentedfreeofanycontrolorinfluenceofacommercialsupporter.SpeakersarerequiredtoprovidetoAAGPandprogramparticipantsmeaningfuldisclosureoffinancialinterests,identifypotentialconflictsofinterest,andestablishamechanismtoresolveanyconflictsbeforeanactivityoccurs.Additionally,allspeakers/authorsarerequiredtosignastatement/pledgethattheirmaterialwillbepresentedbasedonthebestavailableevidence‐basedinformationandthatitwillnotbebiasedbyanyfinancialinteresttheymayhaveinanentityproducinghealthcaregoodsorservices.CONTENTMONITORING/REVIEWAAGPhasproceduresinplacetoscreeneducationalmaterialbeforeitispresentedatameetingorpublished.TheCMECommitteemembersreviewhandoutsandslidematerialsforallCMEsessions,whichhaveoutsidefinancialsupport,toensurethat:thesessionsareeducationalandnotpromotional;contentbalanceisevident,reflectingalllegitimateperspectivesofanissue,atherapeuticapproach,oruseofamedicaldevice(ifbalanceisnotpossible,thesessioniseliminatedorrationaleforinclusionexplainedtotheaudience);peer‐reviewedreferencesareprovided;conclusionsareonlydrawnwhentruecomparisonshavebeenmade;amongotherproceduralcriterialistedinAAGPContinuingMedicalEducationPoliciesforDisclosureandConflictofInterest.TheCMECommitteenotestothefacultyanychangesthatmustbemadeinorderforthepresentationtobemadeattheAAGPAnnualMeeting.DuringtheAnnualMeeting,eachindustry‐supportedsymposiapresentationismonitoredandreporteduponbyAAGPBoardmembersandothervolunteers.Aswithallsessions,attendeesareprovidedwiththeopportunityforevaluationandfeedback.Ifeitherindividualevaluationsreflectabiasedpresentationand/ortheBoardmonitorsreportaninappropriatepresentation,theCMECommitteereviewsthecontentandtapesofthesessionand,ifappropriate,sanctionsareimplemented.TheCMECommitteereportstotheAAGPBoardofDirectorsonallviolationsandresolutionsofinappropriatepresentationsorviolationsofAAGP’sCMEpolicies.DISCLOSURESFROMPLANNINGCOMMITTEE,REVIEWINGCOMMITTEEANDBOARDOFDIRECTORSAllCommitteemembersinapositiontoinfluencethecontentofaneducationalactivity,aswellasallBoardmembers,arerequiredtocompleteandsubmitthePlanningCommitteeDisclosureForm.CONCLUSIONAAGP’sguidelinesareintentionallycomprehensiveandcomplianceisrigorouslymonitoredbyCommitteeandBoardmembersandstafftoprovidehigh‐qualityeducationalexperiencesforallparticipants.Tocontinuouslyimproveeducationalactivities,theAssociationevaluatesitsrulesandprocedureseachyear.DISCLAIMER:Participantshaveanimpliedresponsibilitytousethenewlyacquiredinformationtoenhancepatientoutcomesandtheirownprofessionaldevelopment.Theinformationpresentedinthisactivityisnotmeanttoserveasaguidelineforpatientmanagement.Anyprocedures,medications,orothercoursesofdiagnosisortreatmentdiscussedinthisactivityshouldnotbeusedbyclinicianswithoutevaluationofpatientconditionsandpossiblecontraindicationsondangersinuse,reviewofanyapplicablemanufacturer’sproductinformation,andcomparisonwithrecommendationsofotherauthorities.DisclosureofUnlabeledUse:Thiseducationalactivitymaycontaindiscussionofpublishedand/orinvestigationalusesofagentsthatarenotindicatedbytheFDA.TheAmericanAssociationofGeriatricPsychiatristsdoesnotrecommendtheuseofanyagentoutsideofthelabeledindications.Theopinionsexpressedintheeducationalactivityarethoseofthefacultyanddonotnecessarilyrepresenttheviewsofanyorganizationassociatedwiththisactivity.Pleaserefertotheofficialprescribinginformationforeachproductfordiscussionofapprovedindications,contraindications,andwarnings.

25  

CONFLICTOFINTERESTDISCLOSURESFORTHE2014AAGPPROGRAMFACULTYJanetAbrams,MSWNothingtodiscloseDeepaAcharya,PhD NothingtodiscloseMarcAgronin,MDNothingtodiscloseHowardAizenstein,MD NothingtodiscloseGeorgeAlexopoulos,MDResearchSupport:Forest:GrantConsultant:Pfizer:AdvisoryBoard;Otsuka:AdvisoryBoardSpeakersBureau:AstraZeneca:Speaker;Avanir:Speaker;Novartis:Speaker;Sunovion:SpeakerAllanAnderson,MDNothingtodisclosePatriciaArean,PhDNothingtodiscloseCatherineAyers,PhD,ABPPNothingtodiscloseArnabhBasu,MBBSNothingtodiscloseKishaBazelais,PhDNothingtodiscloseMarianneBergheim,MDNothingtodisclosePaulBlackburn,MD NothingtodiscloseMaryBlazek,MDNothingtodiscloseDonaldBliwise,PhD Consultant:FerringPharmaceuticals:ResearchAdvisor;NewEnglandResearchInstitute:ResearchAdvisorDanielBlumberger,MD,MSc,FRCPCResearchSupport:BrainswayLtd.:ResearchsupportforaninvestigatorInitiatedStudyHillaryBogner,MD,MSCE NothingtodiscloseIstvanBoksay,MD,PhDNothingtodisclose

26  

RobertBoland,MDNothingtodiscloseLeoBorrell,MDNothingtodiscloseJamesBouknight,MD,PhDNothingtodiscloseMalazBoustani,MD,MPHNothingtodiscloseJoyceBromberger,PhDNothingtodiscloseWilliamBrooks,MDNothingtodisclosePatrickBrown,PhD NothingtodiscloseMarthaBruce,PhD,MPHNothingtodiscloseSarahBrunelle,MD NothingtodiscloseIsisBurgos‐Chapman,MDNothingtodiscloseEveByrd,MSNOther:FuquaFoundation:SalarySupport;JesseeParkerWilliamsFoundation:SalarySupportMirnovaCeïde,MDNothingtodiscloseJosephaCheong,MDNothingtodiscloseHenryChung,MD Consultant:PfizerPharmaceuticals:educateaboutACO's;TakedaPharmaceuticals:reviewdataforRCTofnewdrug;SunovionPharmaceuticals:reviewRCTdatafornewindicationCarlCohen,MDNothingtodiscloseChristopherColenda,MDNothingtodiscloseYeatesConwell,MDNothingtodiscloseKathyCronkite JacquelineDecker,DONothingtodisclose

27  

AndrewDentino,MD,FAPA NothingtodiscloseDavangereDevanand,MD ResearchSupport:EliLilly:Investigator‐initiatedgrantJeremyDoughan,PsyD NothingtodiscloseRanjanDuara,MD,FAANConsulting:Bristol‐MyersSquibb,EliLillyandCompanyResearch:AvidRadiopharmaceuticals,GEHealthcare,EliLillyandCompany,MerckandCo.,PfizerInc.,NavideaKellyDunn,MD NothingtodiscloseJamesEllison,MDNothingtodiscloseGaryEpstein‐Lubow,MdNothingtodiscloseRandallEspinoza,MD,MPH NothingtodiscloseJovierEvans,PhDNothingtodiscloseSarahFayad,MDNothingtodiscloseJenniferFelger,PhD NothingtodiscloseLeilaniFeliciano,PhD NothingtodiscloseSanfordFinkel,MDNothingtodiscloseBrentForester,MDResearchSupport:NIMH:ResearchFunding;RogersFamilyFoundation:ResearchFundingGeraldineFox,MD,MHPE NothingtodiscloseDamienGallagher,MB,MD,MRCPsych NothingtodiscloseEricaC.Garcia‐Pittman,MD NothingtodiscloseJenniferGatchel,MD,PhD Nothingtodisclose

28  

JulietGlover,MDNothingtodiscloseRobertGreenberg,MDNothingtodiscloseDavidGreenspan,MDNothingtodiscloseFaithGunning‐Dixon,PhD NothingtodiscloseShujaHaque,MD NothingtodiscloseMelodeeHarris,APN NothingtodisclosePhilipHarvey,PhD Consultant:Abbvie:drugdevelopment;Boeheringer‐Ingelheim:drugdevelopment;ForestLabs:drugdevelopment;Genentech:drugdevelopment;RochePharma:drugdevelopment;Sunovion:drugdevelopmentDilipJeste,MDNothingtodiscloseKevinJohnsonNothingtodiscloseJordanKarp,MDResearchSupport:Pfizer:providedmedicationsuppliesforinvestigatorinitiatedtrial;ReckittBenckiser:providedmedicationsuppliesforinvestigatorinitiatedtrialCharlesKellner,MDNothingtodiscloseGaryKennedy,MDNothingtodiscloseDimitrisKiosses,PhD NothingtodiscloseJoelKirson,MD NothingtodisclosePaulKirwin,MDNothingtodiscloseSibelKlimstra NothingtodiscloseRobertKohn,MD NothingtodiscloseJohnKasckow,MD,PhDOther:BoschHelathCare:Theyhelpedcoversomeofthecostsinourtrialwhichinvolvedtelehealthsystems

29  

HelenKyomen,MDResearchSupport:UCBPharmaMelindaLantz,MDNothingtodiscloseTimLau,MD,FRCPC,MSC NothingtodiscloseHelenLavretsky,MDResearchSupport:ForestResearchInstitute:Researchgrants;Alzheimer'sresearchandpreventionfoundation:researchgrantConsultant:Lilly:consultantJeremyLazarus,MDNothingtodiscloseSuzeeLee,MDResearch:Philips/RespironicsConsultant:Merck,Jazz,VandaStockownership:Teva,ExpressscriptsSusanLehmann,MD NothingtodiscloseEricLenze,MDResearchSupport:Lundbeck,Johnson&Johnson,andRoche:nopersonalincomeBenjaminLiptzin,MDNothingtodiscloseMariaLlorente,MDOther:Forrest:donationofmedicationforstudytoVABarbaraLubranodiCiccone,MD NothingtodiscloseJoseLuchsinger,MD,MPH NothingtodiscloseJayLuxenberg,MDNothingtodiscloseJeffreyLyness,MDNothingtodiscloseSusanMaixner,MDNothingtodisclosePaulaMarcus,MDNothingtodiscloseLauraMarrone,MDNothingtodisclose

30  

LauraMarsh,MD Consultant:RochePharmaceutical:DesignofclinicaltrialsResearchSupport:NIRD/NIHDystoniaFoundation:Investigator;AmericanPsychiatricAssociation:InvestigatorOther:TaylorandFrancis/Informa:RoyaltiesWilliamMcCall,MDResearchSupport:NIMH:researchintoinsomniaanddepression;Merck:researchintodepressionOther:Lippincottpublishers:EditorJECTConsultant:LuitpoldPharmaceuticals:consultantre:ECTShawnMcClintock,PhD,MSCS Consultant:ShireDevelopment:ConsultantWilliamMcDonald,MD ResearchSupport:NIH‐ORD/NINDS:investigatoronstudyofpsychiatricsymptomsindystonia;HRSA:investigatoronlatelifedepressiongrant;CervelNeurotech:PIonstudyofTMS;StanleyFoundation:PIonstudyoftDCSConsultant:APA:CouncilonResearchandQualityOther:AJGP;JECT;FrontiersinNeuropsychiatricImagingandStimulation;InternationalScholarlyResearchNetwork:EditorialBoard;OxfordUniversityPress:editorofbookonTMS;AmericanMedicalForum:paidCMEtalkondepressioninelderlyShareholder:NovartisAG:familymember;JohnsonandJohnson:retirementaccount;NikolausMcFarland,MD,PhD NothingtodisclosePaulMeesters,MD,PhDNothingtodiscloseDavidMerrill,MD,PhD NothingtodiscloseBarnettMeyers,MD NothingtodiscloseBrianaMezuk,PhD NothingtodiscloseMarkMiller,MDNothingtodiscloseArnaldoMoreno,MD NothingtodiscloseBenoitMulsant,MD,MS,FRCPCResearchSupport:Pfizer:MedicationprovidedforaNIMH‐fundedtrial;BMS:MedicationprovidedforaNIMH‐fundedclinicaltrialShareholder:GeneralElectric:Lessthan$5,000ShrutiMutalik,MD NothingtodiscloseAndrewNamen,MD Nothingtodisclose

31  

MaureenNash,MDNothingtodiscloseJ.CraigNelson,MDConsultant:BristolMyersSquibb:consultfortrialdesign;CenestraHealth:onadvisoryboard;Corcept:consultation;EliLilly:consultationandadvisoryboard;Medtronic:datasafetymonitoring;Mylan:consultant;Otsuka:datasafetymonitoring;Pfizer:datasafetymonitoring;Sunovion:consultant,adboard;Theracos:datasafetymonitoringOther:KoreaOIAA(OtsukaInternationalAsiaArab)Co.,Ltd:lecturesoutsideUSShareholder:AtossaGenetics:initialstockholderGeorgeNiederehe,PhDNothingtodiscloseRuthO'Hara,PhDNothingtodiscloseDavidOslin,MDNothingtodiscloseMarthaPayne,PhD,RD,MPH NothingtodiscloseAdrianaSofiaP. Perilla,MA NothingtodiscloseGeorgiosPetrides,MDResearchSupport:NIMH;Amgen;StJudeMedical;CorceptTherapeutics;AstraZenecaYolondaPickett,MD,MSNothingtodiscloseDennisPopeo,MD NothingtodiscloseTarekRajji,MD NothingtodiscloseMarkRapoport,MDOther:CAGP:BoardPresidentHowardReich NothingtodiscloseBarryReisberg,MDOther:BarryReisberg,M.D.hasdevelopedclinicalassessmentinstrumentsforwhichheisthecopyrightholder,whichcanbeusedincapacityassessments.SallyRicketts,MDNothingtodiscloseStevenRoose,MD NothingtodiscloseSusanRose,PhD,NPNothingtodisclose

32  

JulesRosen,MDNothingtodiscloseAdamRosenblatt,MDNothingtodiscloseBretRutherford,MD NothingtodiscloseAdharshSahadevan,MD,MPHNothingtodiscloseMarthaSajatovic,MDResearchgrants:Pfizer,Merck,Ortho‐McNeilJanssen,ReuterFoundation,WoodruffFoundation,ReinbergerFoundation,NationalInstituteofHealth(NIH),CentersforDiseaseControl(CDC);Consultant:UnitedBioSourceCorporation(Bracket),Prophase,Otsuka,Pfizer,Amgen;Royalties:SpringerPress,JohnsHopkinsUniversityPress,OxfordPress,LexicompSharonSalley,MSWNothingtodiscloseElizabethSantos,MDNothingtodiscloseClifford Saper,MD,PhDNothingtodisclose JasonSchillerstrom,MDNothingtodiscloseSusanSchultz,MDEmployment/LeadershipPosition:DeputyEditor,AmericanJournalofPsychiatryGrant/ResearchSupport:Alzheimer'sDiseaseCooperativeStudy,BaxterHealthcareSteveSeiner,MDNothingtodiscloseDanielSewell,MDResearchSupport:NationalInstituteofMentalHealth:GrantfundingOther:TheJohnAHartfordFoundation:GrantfundingConsultant:TheHealthcareGroupInc:PaidmemberofthemedicaladvisoryboardmemberShareholder:TravelingEducationalPresentations,Inc:PresidentandPrincipalShareholderInnaSheyner,MD,CMD NothingtodiscloseJoAnneSirey,PhDNothingtodisclose

33  

GarySmall,MDResearchSupport:POMWonderful:ClinicaltrialsupportSpeakersBureau:Novartis:Alzheimer'sdiagnosis/treatmentConsultant:Novartis:Alzheimer'sdiagnosis/treatmentOther:Herbalife:Writing/speakingonbrainfitnessShareholder:CTEM,LLC:BrainimagingcompanyOther:WorkmanPublishing:Brainhealthbooks;NewsmaxMedia:MindhealthnewsletterMoiraSmoski,PhD NothingtodiscloseTeepaSnow,MD,OTR/LNothingtodiscloseBarbaraSparacino,MDNothingtodiscloseAdamSpira,PhDNothingtodisclose ShilpaSrinivasan,MDNothingtodiscloseDavidSteffens,MDNothingtodiscloseElliottStein,MDNothingtodiscloseMaxStek NothingtodiscloseJonathanStewart,MDNothingtodiscloseJoelStreim,MDNothingtodiscloseUmaSuryadevara,MDNothingtodiscloseSandraSwantek,MDNothingtodiscloseKatalinSzanto,MDNothingtodiscloseJunjiTakeshita,MDNothingtodiscloseWarrenTaylor,MD,MHScNothingtodiscloseAlexanderThrelfall,MDNothingtodisclose

34  

JurgenUnutzer,MDNothingtodiscloseIpsitVahia,MDNothingtodiscloseMollyWagster,PhDNothingtodiscloseDavidWasserman,MANothingtodiscloseDanielWeintraub,MDNothingtodiscloseJulieWetherell,PhDNothingtodiscloseEllenWhyte,MDResearchSupport:NIMH;NICHD/NMCRR;DOD;Lilly:researchsupplies;Pfizer:researchsuppliesIlseWiechers,MDNothingtodiscloseKirstenWilkins,MDNothingtodiscloseKristineYaffe,MDNothingtodisclosePhyllisZee,MD,PhD Research:Philips/RespironicsConsultant:Merck,Jazz,VandaStockownership:Teva,Expressscripts

35  

CONFLICTOFINTERESTDISCLOSURESFORTHE2014AAGPPROGRAMCOMMITTEE(PLANNERS):

MelindaS.Lantz,MD,ChairNothingtoDisclose.ChrisAbbott,MDNothingtoDisclose.JanetAbrams,MSWNothingtoDisclose.MarcE.Agronin,MDNothingtoDisclose.AliAbbasAsghar‐Ali,MDNothingtoDisclose.LisaLynnBoyle,MDNothingtoDisclose.GretchenBrenes,PhDGrant/ResearchSupport:NIMHEveHeemannByrd,MSNNothingtoDisclose.MohitPawanChopra,MDNothingtoDisclose.ColinDepp,PhDNothingtoDisclose.LauraDunn,MDGrant/ResearchSupport:HealthCareChaplaincyConsultant/AdvisoryRole:ABPNGeriatricPsychiatryExamCommitteeOwnershipInterest:Merck(stockownership)DeniseFeil,MDNothingtoDisclose.YunFreudenberg‐Hua,MDNothingtoDisclose.MustafaM.Husain,MDGrant/ResearchSupport:NIH/NIMH,NIDA,NINDS,NIA,NARSD,StanleyFoundation,Cyberonics,Neuronetics(past),St.JudeMedical(ANS),MagStim(equiponly),Brainsway,NeoSync,Alkmers,CorceptJordanF.Karp,MDGrant/ResearchSupport:Pfizer:medicationsuppliedforIIT;ReckittBenckiser:medicationsuppliedforIITShareholder:Corcept:ownstockPaulD.S.Kirwin,MDNothingtoDisclose.MariaI.Lapid,MDNothingtoDisclose.

36  

HelenLavretsky,MDGrant/ResearchSupport:ForestConsultant/AdvisoryRole:LillySusanW.Lehmann,MDNothingtoDisclose.DonovanMaust,MDNothingtoDisclose.DineshMittal,MDNothingtoDisclose.PaulNewhouse,MDNothingtoDisclose.EdwinJ.Olsen,MD,JD,MBANothingtoDisclose.AmitaRajeshPatel,MDHonoraria:Avanir,Otsuka,Novartis,AstraZenecaMarkRapoport,MDNothingtoDisclose.MercedesRodriguez‐Suarez,MDNothingtoDisclose.SamirA.Sabbag,MDNothingtoDisclose.ElizabethJoySantos,MDNothingtoDisclose.JasonE.Schillerstrom,MDNothingtoDisclose.SusanK.Schultz,MDEmployment/LeadershipPosition:DeputyEditor,AmericanJournalofPsychiatryGrant/ResearchSupport:Alzheimer'sDiseaseCooperativeStudy,BaxterHealthcareDanielD.Sewell,MDEmployment/LeadershipPosition:UniveristyofCalifornia,SanDiegoGrant/ResearchSupport:NIHGrantP30MH080002,PI:DilipJeste;JohnAHartfordFoundationCenterofExcellenceinGeropsychiatryGrantformyroleastheassociatedirectorforthephysicianeducatortrackConsultant/AdvisoryRole:MedicalAdvisoryBoardmemberforActivCare,Inc.OwnershipInterest:President,TravelingEducationalPresentationsInc.TatyanaShteinlukht,MDNothingtoDisclose.LuisaSkoble,MDOwnershipInterest:AmericanHomeProducts(smallamtofstock)

37  

MoiraSmoski,MDNothingtoDisclose.ShilpaSrinivasan,MDNothingtoDisclose.WarrenD.Taylor,MDNothingtoDisclose.AlexanderThrelfall,MDNothingtoDisclose.IpsitVahia,MDHonoraria:Am.J.ofGeriatricPsychiatryDeborahB.Wagenaar,DO,MSNothingtoDisclose.JulieWetherell,PhDNothingtoDisclose.EllenM.Whyte,MDGrant/ResearchSupport:NIMH,NICHD/NCMRR,DOD,Pfizer(Researchsupplies),Lilly(Researchsupplies)

38  

CONFLICTOFINTERESTDISCLSOURESFORTHEAAGPBOARDOFDIRECTORS(PLANNERS):

DavidSteffens,MD FinancialCompensation:TextbookroyaltiesfromAmericanPsychiatricAssociation–APPIPress.PaulKirwin,MD Governance:AmericanBoardofInternalMedicine,GeriatricCommittee,ABPNRepresentative–dailystipendforcommitteemeeting.Consulting:GlobalMedicalAdvisoryBoard,Americares(non‐paid).SusanSchultz,MDGovernance:AmericanPsychiatricAssociation,CouncilonGeriatricPsychiatry.FinancialCompensation:AmericanPsychiatricAssociation,supportforeditorialduties,AmericanJournalofPsychiatryLauraDunn,MDResearchSupport:NIH,HealthCareChaplaincy,DepartmentofDefenseGovernance:ABPNGeriatricPsychiatryExamCommitteeOther:Stockownership‐MerckMelindaLantz,MDOther:IPRO–UtliizationReview;MDReview–UtilizationReviewMarcAgronin,MDCompensation:Receivedanhonorariumforparticipatinginasymposiumatthe2012AnnualMeeting.Financial:NovartisPharmaceuticals–Speaker’sbureauforExelonPatch.Accera–Speaker’sbureauforAxona.Avanir–Speaker’sbureauforNuedexta.AssureRx–Speaker’sbureau/consultantforGeneSighttestMarthaBruce,PhDOther:ServedasapaidreviewertoMcKesson,Inc.inSpring2012.ResearchSupport:PIofanNIHgrantthathasasubcontractwithCareAnyware,Inc.EveHeemannByrd,MSN Other:AlthoughanEmoryEmployee,themajorityofmysalaryissupportedbyagiftfromtheFuquaFoundationtotheUniversityBrentForester,MDGrantSupport:NIMH,RogersFamilyFoundationConsultant:LibertyMutual–DisabilityClaimsReviewGovernance:BoardMember,Alzheimer’sAssociationofMA/NHBlaineGreenwald,MD Governance:APACouncilonGeriatricPsychiatryEricLenze,MDResearchSupport:Lundbeck,Johnson&Johnson,RocheMaureenNash,MDOther:OwnerofCliniciansPresswhichistobecomeabookpublishingendeavor.PaulNewhouse,MDResearchSupport:ElanLarryTune,MDNothingtodisclose.

39  

EllenWhyte,MDResearchSupport:NIMH,NICHD/NCMRR,DODIsisBurgos‐Chapman,MD Noconflictstodisclose.

40  

CONFLICTOFINTERESTDISCLOSURESFORTHECME/EDUCATIONCOMMITTE(REVIEWERS):

LisaLynnBoyle,MD,ChairEmployment/Leadership:UniversityofRochester;Grant/ResearchSupport:GeriatricAcademicCareerAward‐HRSAMuhammadAslam,MDHonoraria:Takeda/LundbeckPharmaceuticalDanielBateman,MDNothingtoDisclose.DavidBeck,MDNothingtoDisclose.MarieDeWitt,MDNothingtoDisclose.LindaGarand,PhDNothingtoDisclose.HelenKyomen,MDEmployment/Leadership:Consultant–AstraZenecaPharmaceuticals,LP;BayerCorporation;BristolMyersSquibbCo.;Merck&Co.,Inc.;EliLilly&Co.,;RochePharmaceuticals;GlaxoSmithKline;NovartisPharmaceuticalsCorp.,UCBPharma;Wyeth‐AyerstLaboratories;Pfizer,Inc.Grant/ResearchSupport:BayerCorp.;Bristol‐MyersSquibbCo.;EliLilly&Co.;RochePharmaceuticals;UCBPharma;Wyeth‐AyerstLaboratories;PfizerInc.;NIHInstitute;TheJohnA.HarfordFoundation;NationalInstituteonAging;VeteransAdministrationOtherMemberships:GroupforAdvancementofPsychiatryCommitteeonAging;AmericanPsychiatricAssociationCouncilonAdultPsychiatry;AmericanAssociationforGeriatricPsychiatryBoardWilliamM.McDonald,MDResearchSupport:NIH‐ORD/NINDS:investigatoronstudyofpsychiatricsymptomsindystonia;HRSA:investigatoronlatelifedepressiongrant;CervelNeurotech:PIonstudyofTMS;StanleyFoundation:PIonstudyoftDCSConsultant:APA:CouncilonResearchandQualityOther:AJGP;JECT;FrontiersinNeuropsychiatricImagingandStimulation;InternationalScholarlyResearchNetwork:EditorialBoard;Shareholder:NovartisAG:familymember;Shareholder:JohnsonandJohnson:retirementaccount;OxfordUniversityPress:editorofbookonTMS;AmericanMedicalForum:paidCMEtalkondepressioninelderlyDineshMittal,MDNothingtoDisclose.MaryMorrison,MD,MSGrant/ResearchSupport:AstraZenecaAlessandraScalmati,MDNothingtoDisclose.DanielD.Sewell,MDEmployment/Leadership:UniversityofCalifornia,SanDiegoGrant/ResearchSupport:NIHGrantP30MH0080002,PI:DilipJeste;JohnAHartfordFoundationCenterofExcellenceinGeropsychiatryGrantformyroleastheassociatedirectorforthephysicianeducatortrackConsultant/AdvisoryRole:MedicalAdvisoryBoardofActivCareInc.OwnershipInterest:PresidentofTravelingEducationalPresentations,Inc.

41  

TatyanaP.Shteinlukht,MD,PhDNothingtoDisclose.SandraSwantek,MDEmployment/Leadership:SectionChief,GeriatricPsychiatry,RushUniversityMedicalCenterOther:BoardMember,ExecutiveCommitteeMemberandSecretary,BlowitzRidgewayFoundationRajeshR.Tampi,MD,MS,FAPAOther:OakstonePublishing,Inc.1)EditorialBoardMember,PsychiatricReviews,2)PresenterAnnualPsychiatryBoardReviewAlexanderThrelfall,MDNothingtoDisclose.AAGPPROGRAMPLANNINGSTAFF:ChristineM.deVriesNoconflictstodiscloseKateMcDuffieNoconflictstodiscloseMarjorieVanderbiltNoconflictstodisclose

42  

American Association for Geriatric Psychiatry 7910 Woodmont Avenue, Suite 1050

Bethesda, MD 20814 301-654-7850

www.AAGPonline.org www.AAGPmeeting.org